EU Commission calls for data on prostaglandins citing safety

The European Commission is seeking scientific information that would be relevant to the safety assessment of the use of prostaglandins and their analogues(namely isopropyl cloprostenate, bimatoprost, tafluprost and other synthetic analogues) in cosmetic products. Prostaglandins are lipids that help recovery at spots of tissue damage or infection. A 2018 assessment by the German Federal Institute for Risk Assessment (BfR) found that these substances are in products intended to promote the growth of eyelashes, and may pose health risks for consumers. The Commission is inviting interested parties, such as research institutes, EU authorities and manufacturers to provide data on physico-chemical properties, toxicokinetics, toxicological endpoints and suggested safe concentration limits on the substances.The information will feed into a future assessment by the EU Scientific Committee for the Safety of Consumers (SCCS).

Subscribe to our free newsletter to read the latest news and articles before they are published.